Understanding the delicate balance between bleeding and thrombosis: Can we use it to our advantage?

Journal of Extra-Corporeal Technology

Volumn 44, Issue 1, 2012, Pages

  Somer, Filip De ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cardiac surgery; Cell based hemostasis

Indexed keywords

BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING FACTOR 9A; CLOPIDOGREL; FIBRINOGEN; FIBRONECTIN; VON WILLEBRAND FACTOR;

ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TEST; CARDIOPULMONARY BYPASS; CELL INTERACTION; HEMOSTASIS; HUMAN; LABORATORY TEST; PARTIAL THROMBOPLASTIN TIME; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY; THROMBOSIS; BLOOD CLOTTING; CARDIOVASCULAR SURGERY; METHODOLOGY; PATHOPHYSIOLOGY;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; CARDIOVASCULAR SURGICAL PROCEDURES; HEMORRHAGE; HEMOSTASIS; HUMANS; THROMBOSIS;

EID: 84864303381     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Patrono C, Bachmann F, Baigent C, et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. Eur Heart J. 2004;25:166-81.
2. Korte W, Cattaneo M, Chassot PG, et al. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: Joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (OGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost. 2011;105:743-9.
3. Picker SM, Kaleta T, Hekmat K, et al. Antiplatelet therapy preceding coronary artery surgery: Implications for bleeding, transfusion requirements and outcome. Eur J Anaesthesiol. 2007;24:332-9.
4. Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958-65.
5. Monroe DM, Hoffman M. What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol. 2006;26:41-8.
6. Vallely MP, Bannon PG, Bayfield MS, et al. Quantitative and temporal differences in coagulation, fibrinolysis and platelet activation after on-pump and off-pump coronary artery bypass surgery. Heart Lung Circ. 2009;18:123-30.
7. Aldea GS, Soltow LO, Chandler WL, et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg. 2002;123:742-55.
8. De Somer F, Van Belleghem Y, Caes F, et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2002;123:951-8.
9. Mengistu AM, Mayer J, Boldt J, et al. Usefulness of monitoring platelet function by multiple electrode aggregometry in primary coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2011;25:42-7.
10. Mengistu AM, Wolf MW, Boldt J, et al. Evaluation of a new platelet function analyzer in cardiac surgery: A comparison of modified thromboelastography and whole-blood aggregometry. J Cardiothorac Vasc Anesth. 2008;22:40-6.
11. Mengistu AM, Wolf MW, Boldt J, et al. Evaluation of a new platelet function analyzer in cardiac surgery: A comparison of modified thromboelastography and whole-blood aggregometry. J Cardiothorac Vasc Anesth. 2008;22:40-6.
12. Jambor C, von Pape KW, Spannagl M, et al. Multiple electrode whole blood aggregometry, PFA-100, and in vivo bleeding time for the point-of-care assessment of aspirin-induced platelet dysfunction in the preoperative setting. Anesth Analg. 2011;113:31-9.
13. De Somer F, Francois K, van Oeveren W, et al. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardiothorac Surg. 2000;18:602-6.
14. Straub A, Schiebold D, Wendel HP, et al. Platelet anaesthesia during extracorporeal circulation: Differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia. Thromb Res. 2008;122:383-9.
15. Straub A, Azevedo R, BeierleinW, et al. Tirofiban (Aggrastat) protects platelets and decreases platelet-granulocyte binding in an extracorporeal circulation model. Thorac Cardiovasc Surg. 2006;54:162-7.
16. Straub A, Azevedo R, Beierlein W, et al. Glycoprotein IIb/IIIa inhibition reduces prothrombotic events under conditions of deep hypothermic circulatory arrest. Thromb Haemost. 2005;94:115-22.
17. Funakubo A, Taga I, McGillicuddy JW, et al. Flow vectorial analysis in an artificial implantable lung. ASAIO J. 2003;49:383-7.
18. Chen S, Jones JA, Xu Y, et al. Characterization of topographical effects on macrophage behavior in a foreign body response model. Biomaterials. 2010;31:3479-91.
19. Dewanjee MK, Kapadvanjwala M, Mao WW, et al. A higher blood flow window of reduced thrombogenicity and acceptable fragmentation in a hollow fiber hemodialyzer. ASAIO J. 1993;39:M363-7.
20. Litmathe J, Philipp C, Kurt M, et al. The use of autologous platelet gel (APG) for high-risk patients in cardiac surgery-Is it beneficial? Perfusion. 2009;24:381-7.
21. Buchwald D, Kaltschmidt C, Haardt H, et al. Autologous platelet gel fails to show beneficial effects on wound healing after saphenectomy in CABG patients. J ECT. 2008;40:196-202.
22. Passage J, Jalali H, Tam RK, et al. BioGlue surgical adhesive-An appraisal of its indications in cardiac surgery. Ann Thorac Surg. 2002;74:432-7.
23. Zeiger E, Gollapudi B, Spencer P. Genetic toxicity and carcinogenicity studies of glutaraldehyde-A review. Mutat Res. 2005;589:136-51.
24. LeMaire SA, Schmittling ZC, Coselli JS, et al. BioGlue surgical adhesive impairs aortic growth and causes anastomotic strictures. Ann Thorac Surg. 2002;73:1500-5; discussion 1506.
25. Lemaire SA, Ochoa LN, Conklin LD, et al. Nerve and conduction tissue injury caused by contact with BioGlue. J Surg Res. 2007;143:286-93.
26. Luthra S, Theodore S, Tatoulis J. Bioglue: A word of caution. Ann Thorac Surg. 2008;86:1055-6; author reply 1056-7.
27. De Somer F, Delanghe J, Somers P, et al. Mechanical and chemical characteristics of an autologous glue. J Biomed Mater Res A. 2008;86:1106-12.
28. Van Nooten GJ, Somers P, Forsyth R, et al. Autologous glue: Part of the sticky mystery unraveled. J Thorac Cardiovasc Surg. 2007;134:415-23.